See today's BioWorld Science
To read the full story, subscribe or sign in.
Ear, Nose & Throat

Sensorion submits CTA in UK for OTOF-GF for otoferlin gene-mediated hearing loss

July 10, 2023
No Comments
Sensorion SA has submitted a clinical trial application (CTA) for OTOF-GT to the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA). Sensorion plans to submit the CTA in Europe in the coming weeks.
BioWorld Science Ear, nose and throat Gene therapy MHRA